Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Stages of General Anesthesia01:22

Stages of General Anesthesia

298
Various sedation levels offer significant advantages in facilitating procedural interventions for patients undergoing medical or invasive surgical procedures. These levels span from anxiolysis to general anesthesia, providing a spectrum of sedative effects to cater to specific patient needs. Anxiolysis reduces anxiety and is achieved through minimal sedation, enabling patients to remain awake and responsive while feeling more at ease during the procedure. This level can benefit minor...
298
Sedatives and Hypnotics: Overview01:23

Sedatives and Hypnotics: Overview

205
Sedatives are drugs that alleviate anxiety, while hypnotics induce sleep. Both classes of medication suppress neuronal activity, leading to a calming effect for sedatives and facilitating sleep for hypnotics.
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
205
CNS Depressants: Barbiturates and Benzodiazepines01:14

CNS Depressants: Barbiturates and Benzodiazepines

167
CNS depressants include drugs from the category of barbiturates and benzodiazepines. They are valuable medications for managing anxiety disorders and insomnia. Barbiturates, once used to induce and maintain sleep, have been replaced mainly by benzodiazepines due to barbiturate's toxicity, tolerance, and overdose risks. They interact with GABAA receptors, leading to sedation at low doses and potentially coma and death at higher doses. Phenobarbital, a long-acting barbiturate, possesses...
167
Sleepwalking and Sleep Talking01:17

Sleepwalking and Sleep Talking

96
Somnambulism, commonly known as sleepwalking, involves individuals engaging in activities ranging from simple walking to more complex behaviors such as driving. Sleepwalking typically occurs during the slow-wave sleep stages 3 and 4 early in the night when the person is not dreaming, contradicting the myth that sleepwalkers are acting out their dreams.
Factors that increase the likelihood of sleepwalking include sleep deprivation and alcohol consumption. Contrary to common beliefs, it is safe...
96
Depressants01:28

Depressants

90
Depressant drugs, including alcohol and sedative-hypnotics, diminish central nervous system activity by enhancing the action of gamma-aminobutyric acid (GABA), a neurotransmitter that reduces brain activity and promotes relaxation. These substances can have various therapeutic uses but also pose significant risks, especially when misused or combined.
Alcohol is a common depressant that can induce a sense of relaxation and reduced inhibition at low doses. Contrary to its occasional...
90
Sedatives and Hypnotics Drugs: Benzodiazepines01:19

Sedatives and Hypnotics Drugs: Benzodiazepines

120
Benzodiazepines have both sedative and hypnotic properties. They include compounds such as diazepam (Valium) and alprazolam (Xanax). Structurally, their cores are similar, consisting of the fusion of a benzene ring and a diazepine ring, but they share a common mechanism of action in the central nervous system (CNS).
Benzodiazepines work by enhancing the effects of the inhibitory neurotransmitter GABA. They bind to the GABAA receptor, increasing its affinity for GABA, which opens chloride...
120

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Non-occupational post-exposure prophylaxis does not expand or differentiate candidates for pre-exposure prophylaxis.

Sexual health·2026
Same author

Real-world management and long-term outcomes in adolescent, young adult, and adult medulloblastoma: Experience from a monocentric series with multimodal and targeted approaches.

Neuro-oncology practice·2026
Same author

"Prevalence of Peri-Implant Diseases in Patients With Type 2 Diabetes Mellitus: A Cross-Sectional Study".

Clinical and experimental dental research·2026
Same author

Clinical Characteristics at the Diagnosis of New Primary Melanoma in Italy: A Multicenter Retrospective Study Before and After the COVID-19 Pandemic.

Journal of clinical medicine·2026
Same author

From stress to success: using physiological data to predict cardiopulmonary resuscitation simulation performance.

Frontiers in psychology·2026
Same author

Recovery Experiences of Older Adults and Their Caregivers After Major Elective Noncardiac Surgery.

JAMA network open·2026

Related Experiment Video

Updated: May 10, 2025

SECONDs Administration Guidelines: A Fast Tool to Assess Consciousness in Brain-injured Patients
11:05

SECONDs Administration Guidelines: A Fast Tool to Assess Consciousness in Brain-injured Patients

Published on: February 6, 2021

14.2K

Driving ability after conscious sedation: a systematic review.

Matteo Melini1,2, Francesco Cavallin3, Andrea Forni4

  • 1Section of Clinical Dentistry, Department of Neurosciences, University of Padua, Padua, Italy - drmatteomelini@gmail.com.

Minerva Dental and Oral Science
|April 23, 2025
PubMed
Summary

Driving ability is impaired after conscious sedation (CS), affecting psychomotor and cognitive functions. Patients should avoid driving post-sedation, as recovery time remains undetermined by current research.

More Related Videos

Recording Brain Electromagnetic Activity During the Administration of the Gaseous Anesthetic Agents Xenon and Nitrous Oxide in Healthy Volunteers
14:52

Recording Brain Electromagnetic Activity During the Administration of the Gaseous Anesthetic Agents Xenon and Nitrous Oxide in Healthy Volunteers

Published on: January 13, 2018

10.9K
Drug-Induced Sleep Endoscopy DISE with Target Controlled Infusion TCI and Bispectral Analysis in Obstructive Sleep Apnea
07:54

Drug-Induced Sleep Endoscopy DISE with Target Controlled Infusion TCI and Bispectral Analysis in Obstructive Sleep Apnea

Published on: December 6, 2016

19.5K

Related Experiment Videos

Last Updated: May 10, 2025

SECONDs Administration Guidelines: A Fast Tool to Assess Consciousness in Brain-injured Patients
11:05

SECONDs Administration Guidelines: A Fast Tool to Assess Consciousness in Brain-injured Patients

Published on: February 6, 2021

14.2K
Recording Brain Electromagnetic Activity During the Administration of the Gaseous Anesthetic Agents Xenon and Nitrous Oxide in Healthy Volunteers
14:52

Recording Brain Electromagnetic Activity During the Administration of the Gaseous Anesthetic Agents Xenon and Nitrous Oxide in Healthy Volunteers

Published on: January 13, 2018

10.9K
Drug-Induced Sleep Endoscopy DISE with Target Controlled Infusion TCI and Bispectral Analysis in Obstructive Sleep Apnea
07:54

Drug-Induced Sleep Endoscopy DISE with Target Controlled Infusion TCI and Bispectral Analysis in Obstructive Sleep Apnea

Published on: December 6, 2016

19.5K

Area of Science:

  • Medical research
  • Anesthesiology
  • Patient safety

Background:

  • Conscious sedation (CS) is a common medical procedure.
  • CS can impair psychomotor and cognitive functions, impacting daily activities like driving.
  • Evidence on post-sedation driving ability is fragmented.

Purpose of the Study:

  • To systematically review existing evidence on driving ability after conscious sedation.
  • To summarize direct and indirect evidence regarding post-sedation driving impairment.

Main Methods:

  • Comprehensive literature search across multiple databases (MEDLINE/PubMed, EMBASE, SCOPUS, etc.) up to June 2022.
  • Included randomized and non-randomized controlled trials.
  • Followed PRISMA guidelines and appraised risk of bias.

Main Results:

  • Narrative synthesis of 27 studies involving 962 subjects.
  • Conscious sedation impairs driving ability and cognitive/psychomotor functions (e.g., reaction time, attention) 0.5-10 hours post-administration.
  • Heterogeneity precluded meta-analysis.

Conclusions:

  • Strong recommendation to avoid driving after conscious sedation.
  • Further research is needed to determine the precise recovery time for driving ability.